(PDF) Principles and Practice of Transplant Infectious Diseases by Amar Safdar

This is the PDF eBook version for Principles and Practice of Transplant Infectious Diseases by Amar Safdar

Table of Contents

Front Matter
Part I. Principles of Transplantation and Overview of Infectious Diseases
1. Infections in Transplantation: Introduction and Overview
2. Infections in Heart, Lung, and Heart-Lung Transplantation
3. Infections in Liver Transplantation
4. Infections in Kidney and Pancreas Transplantation
5. Infections in Intestinal and Multivisceral Transplantation
6. Infections in Limbs, Integuments, and Face Transplantation
7. Principles of Hematopoietic Stem Cell Transplantation
8. Infections in Pediatric Transplant Recipients
Part II. Clinical Disorders in Transplant Recipients
9. Febrile Neutropenia in Transplant Recipients
10. Cytopenias in Transplant Patients
11. Infections in Allogeneic Stem Cell Transplantation
12. Complications Arising from Preparatory Conditioning Regimens for Stem Cell Transplantation
13. Intravascular Catheter and Implantable Device Infections in Transplant Patients
14. Surgical Site Infections: Wound and Stump Infections
15. Endovascular Infections and Endocarditis
16. Gastrointestinal Infections and Clostridium difficile Infection
17. Hepatobiliary Tract Infections
18. Ocular Infections in Transplant Patients
19. Intracranial, Spinal, and Paraspinal Infections in the Transplant Recipient
20. Respiratory Tract Infections: Sinusitis, Bronchitis, and Pneumonia
21. Respiratory Tract Diseases That May Be Mistaken for Infection
22. Skin and Soft Tissue Infection in Transplant Recipients
23. Cutaneous Lesions that Mimic Infection in Transplant Patients
Part III. Etiologic Agents in Infectious Diseases
24. Staphylococcus, Streptococcus, and Enterococcus
25. Enterobacteriaceae in Transplantation
26. Pseudomonas, Stenotrophomonas, Acinetobacter, and Other Nonfermentative Gram-Negative Bacteria and Medically Important Anaerobic Bacteria in Transplant Recipients
27. Nocardiosis and Actinomycosis
28. Listeriosis
29. Tuberculosis
30. Nontuberculous Mycobacterial Disease in Transplant Recipients
31. Invasive Fungal Disease in the Transplant Population: An Overview
32. Candida Infections in Hematopoietic and Solid Organ Transplant Recipients
33. Aspergillosis
34. Mucormycosis
35. Cryptococcus Infections in Transplant Recipients
36. Histoplasmosis, Coccidioidomycosis, and Diseases Due to Other Endemic Fungi in Transplant Recipients
37. Cytomegalovirus
38. Epstein-Barr Virus Infection and Posttransplant Lymphoproliferative Disease
39. Herpes Simplex Viruses 1 and 2, Varicella Zoster Virus, and Human Herpes Viruses 6, 7, and 8 in Transplant Recipients
40. Respiratory Viral Infections in Transplant Recipients
41. Hepatitis A, B, and C
42. Enterovirus Infection in Immunocompromised Hosts
43. Parvovirus B19
44. West Nile Virus in Immunocompromised Hosts
45. Rare and Emerging Viral Infections in the Transplant Population
46. Parasitic Infections in Transplant Recipients: Toxoplasmosis, Strongyloidiasis, and Other Parasites
Part IV. Diagnosis of Infectious Diseases in Special Host
47. Impacts and Challenges of Advanced Diagnostic Assays for Transplant Infectious Diseases
48. Diagnosis of Systemic Fungal Diseases
49. Viral Diagnostics
Part V. Therapeutics and Management of Patients Undergoing Transplantation
50. Antibiotic Consideration in Transplant Recipients
51. Pharmacokinetics and Pharmacodynamics of Antibiotics in Transplant Patients
52. Antifungal Consideration for Transplant Recipients
53. Immunomodulatory Properties of Antifungal Agents on Immune Functions of the Host
54. Antiviral Consideration for Transplantation Including Drug Resistance
55. Pharmacokinetics and Pharmacodynamics of Antiviral Drugs in Special Population
56. Antimycobacterial Consideration in Transplantation Including Drug Non-susceptibility and Resistance: Tuberculosis and Nontuberculous Mycobacterial Disease
57. Adaptive Immunotherapy for Opportunistic Infections
58. Immunotherapy for Invasive Mold Disease in Transplant Patients: Dendritic Cell Immunotherapy, Interferon Gamma, Recombinant Myeloid Growth Factors, and Healthy Donor Granulocyte Transfusions
59. Antimicrobial Stewardship: Considerations for a Transplant Center
60. The Use of Palliative Care in Organ Transplant Patients and End-of-Life Issues
Part VI. Infection Prevention
61. Infection Control Strategies in Transplant Populations
62. Travel and Transplantation
63. Vaccination in Organ Transplant Patients
64. Prevention of Fungal Disease
65. Antimicrobial Drug Prophylaxis: Challenges and Controversies
Back Matter